We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
26
Sherwin-Williams
SHW
$89.8B
$262M 1.11%
753,830
-78,262
-9% -$24.9M
CSGP icon
27
CoStar Group
CSGP
$12.3B
$251M 1.06%
2,594,356
-527,000
-17% -$45.4M
MA icon
28
Mastercard
MA
$493B
$247M 1.05%
513,161
-106,310
-17% -$48.6M
RVMD icon
29
Revolution Medicines
RVMD
$44B
$242M 1.03%
7,507,872
+771,018
+11% +$22.9M
HWM icon
30
Howmet Aerospace
HWM
$112B
$233M 0.99%
3,410,759
-1,305,268
-28% -$80M
MASI
31
DELISTED
Masimo
MASI
$219M 0.93%
1,489,563
+177,914
+14% +$23M
AON icon
32
Aon
AON
$76B
$211M 0.89%
+632,000
New +$196M
CNC icon
33
Centene
CNC
$32.5B
$205M 0.87%
2,607,875
-1,524,200
-37% -$118M
YMM icon
34
Full Truck Alliance
YMM
$9.99B
$191M 0.81%
26,285,059
-11,905,436
-31% -$79.4M
V icon
35
Visa
V
$677B
$190M 0.81%
680,850
-117,260
-15% -$32.4M
PTGX icon
36
Protagonist Therapeutics
PTGX
$9.44B
$166M 0.7%
5,738,973
+4,543
+0.1% +$124K
AGIO icon
37
Agios Pharmaceuticals
AGIO
$1.93B
$163M 0.69%
5,590,602
+1,423,000
+34% +$38.1M
BEAM icon
38
Beam Therapeutics
BEAM
$2.84B
$149M 0.63%
4,511,753
+406,000
+10% +$12.6M
CTLT
39
DELISTED
CATALENT, INC.
CTLT
$144M 0.61%
2,550,000
+1,137,000
+80% +$61.6M
INSP icon
40
Inspire Medical Systems
INSP
$1.74B
$135M 0.57%
626,854
-228,242
-27% -$44.7M
X
41
DELISTED
US Steel
X
$130M 0.55%
3,190,000
+740,500
+30% +$33.9M
AZN icon
42
AstraZeneca
AZN
$250B
$98.9M 0.42%
729,859
-1,182,287
-62% -$157M
VSTS icon
43
Vestis
VSTS
$1.88B
$94.7M 0.4%
4,914,753
-555,000
-10% -$11M
AMED
44
DELISTED
Amedisys
AMED
$92.9M 0.39%
1,008,300
+322,300
+47% +$30.2M
LNTH icon
45
Lantheus
LNTH
$6.59B
$92.3M 0.39%
1,483,227
+1,269,900
+595% +$74.7M
ANSS
46
DELISTED
Ansys
ANSS
$88.5M 0.38%
+255,000
New +$86.3M
GBTC icon
47
Grayscale Bitcoin Trust
GBTC
$9.76B
$85.2M 0.36%
+1,493,428
New +$65.7M
COR icon
48
Cencora
COR
$61.2B
$81.2M 0.34%
334,000
+165,000
+98% +$37.9M
THC icon
49
Tenet Healthcare
THC
$21.1B
$67M 0.28%
637,442
+262,600
+70% +$23.6M
SIMO icon
50
Silicon Motion
SIMO
$8.68B
$65.8M 0.28%
855,449
+608,949
+247% +$41.6M

Similar funds

Farallon Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Farallon Capital Management held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Farallon Capital Management added most to Hess in Q1 2024, an estimated $502M increase.
  • Farallon Capital Management's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Farallon Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Farallon Capital Management opened 43 new positions and closed 21 in Q1 2024.
  • Farallon Capital Management's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.